''

Short-Acting Insulin

Short-acting insulins or regular insulins are recombinant human insulins that were developed to mimic normal after-meal insulin release. They are intended to be used as a bolus mealtime insulin to quickly lower the increase in blood glucose (sugar) after eating. Even though they are regular human insulins, they do not end up controlling the after-meal blood glucose like the insulin produced in the body. This is because after regular human insulin is injected it has a delay before it is absorbed into the body. This delays the onset (usually 30 minutes) and prolongs the effect (usually 3-6 hours) of the injected regular insulin. This limits short-acting insulins effectiveness in providing good glucose control and increases the risk of hypoglycemia.

Some of the short-acting insulins available in the US include:

What is Humulin R (regular human insulin)?

Humulin R (regular human insulin) is used with diet and exercise to improve blood glucose control after meals in the treatment of type 2 diabetes. Humulin R is given as a subcutaneous (under the skin) injection 30 minutes before meals.  It can be injected in the abdomen, thigh, or upper arm or buttocks. Injection sites should be rotated each time to prevent the risk of lipodystrophy, an accumulation of fatty tissue under the skin at the site where  insulin  is injected. Consult with your healthcare provider on proper use and to determine the specific dose needed.

More on this topic

Humulin R is available in a vial containing 100 units/ml (Humulin R U-100), a highly concentrated vial containing 500 units/ml (Humulin R U-500), and a highly concentrated pen containing 500 units/ml (Humulin R U-500 Kwikpen). Humulin R U-500 vials must be injected with a U-500 insulin syringe, otherwise life-threatening hypoglycemia may result. Unopened vials and pens should be kept in the refrigerator. Opened Humulin R U-100 vials should be discarded 31 days after opening. Opened Humulin R U-500 vials can be stored at room temperature for up to 40 days. Opened Humulin R U-500 KwikPens should be stored at room temperature after opening and discarded after 28 days.

Some of the most common side effects from Humulin R  include:

  • Hypoglycemia
  • Injection site reactions
  • Weight gain

Some side effects, like anaphylaxis, hypoglycemia, edema, heart failure or diabetic ketoacidosis can be severe and even life threatening. These are not all the possible side effects of Humulin R. Patients should talk to their doctor about what to expect with treatment with Humulin R. Consult your healthcare provider on how to recognize the signs and symptoms of these side effects and let them know if you experience any side effects after using Humulin-R or any other medication. People who are allergic to any of the ingredients in Humulin R should not use it. Always check with your healthcare professional about any potential drug interactions before starting treatment.

What is Novolin R (regular human insulin)?

Novolin R (regular human insulin) is used with diet and exercise to improve blood glucose control after meals in the treatment of type 2 diabetes. Novolin R is given as a subcutaneous (under the skin) injection 30 minutes before meals.  It can be injected in the abdomen, thigh, or upper arm or buttocks. Injection sites should be rotated each time to prevent the risk of lipodystrophy, an accumulation of fatty tissue under the skin at the site where  insulin  is injected. Consult with your healthcare provider on proper use and to determine the specific dose needed.

Novolin R is available in a vial containing 100 units/ml. Store unopened vials in the refrigerator. Opened vials should be stored at room temperature for up to 42 days.

Some of the most common side effects from Novolin R include:

Some side effects, like anaphylaxis, hypoglycemia, edema, heart failure or diabetic ketoacidosis can be severe and even life threatening. These are not all the possible side effects of Novolin R. Patients should talk to their doctor about what to expect with treatment with Novolin R. Consult your healthcare provider on how to recognize the signs and symptoms of these side effects and let them know if you experience any side effects after using Novolin R or any other medication. People who are allergic to any of the ingredients in Novolin R should not use it. Always check with your healthcare professional about any potential drug interactions before starting treatment.

What is Myxredlin?

Myxredlin (human insulin) is the first and only ready-to-use insulin for IV infusion in the hospital and other acute care settings. It is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Myxredlin is intended for use only in acute care settings. It is given intravenously only under medical supervision with close monitoring of blood glucose and potassium levels.

Myxredlin is provided in a standardized concentration of 100 units/100 mL in a flexible plastic container.

Some of the most common side effects from Myxredlin include:

Some side effects, like anaphylaxis, hypoglycemia, low potassium levels, and heart failure can be severe and even life threatening. These are not all the possible side effects of Myxredlin. Patients should talk to their doctor about what to expect with treatment with Myxredlin. People who are allergic to any of the ingredients in Myxredlin should not use it. Always check with your healthcare professional about any potential drug interactions before starting treatment.

By providing your email address, you are agreeing to our privacy policy. We never sell or share your email address.

Written by: Bridget Barvian | Last reviewed: October 2020